Clinical TrialsSearch results
Number of results: 287
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- PEARL5 study
- CD5-positive diffuse large B-cell lymphoma
- Yamaguchi Motoko
- 2019-03-29
Other
- Phase II study of R-CHOP and R-high-dose MTX therapy for IVLBCL
- Intravascular large B-cell lymphoma
- Yamaguchi Motoko
- 2019-03-29
Completed
- Phase I study of nab-paclitaxel and gemcitabine CRT for BR and UR-LA PDAC
- Borderline resectable or locally advanced unresectable pancreatic cancer
- Kishiwada Masashi
- 2019-03-29
Recruiting
- Investigation of mechanisms of pulmonary hypertension due to left heart disease
- Heart Failure
- Dohi Kaoru
- 2019-03-23
Recruiting
- Prevention for Recurrence Of The preEClampsia with TAdalafil
- Hypertension disorder of pregnancy
- Ikeda Tomoaki
- 2019-03-23
Completed
- Optimization of adenosine stress in myocardial perfusion imaging
- Healthy person
- Sakuma Hajime
- 2019-03-14
Completed
- Placebo-controlled randomized, double-blind study of zaltoprofen for patients with diffuse type tenosynovial giantcell tumor (Pigmented Villonodular Synovitis) and unresectable localized tenosynovial giant cell tumor (tendon sheath giant cell tumor) (Phase II study)
- Diffuse type tenosynovial giant cell tumor (Pigmented Villonodular Synovitis) and localized tenosynovial giant cell tumor (tendon sheath giant cell tumor)
- Kanazawa University Hospital
- 2017-04-06
Completed
- Placebo-controlled randomized, double-blind study of zaltoprofen for patients with diffuse type tenosynovial giantcell tumor (Pigmented Villonodular Synovitis) and unresectable localized tenosynovial giant cell tumor (tendon sheath giant cell tumor) (Phase II study)
- Diffuse type tenosynovial giant cell tumor (Pigmented Villonodular Synovitis) and localized tenosynovial giant cell tumor (tendon sheath giant cell tumor)
- Kanazawa University Hospital
- 2017-04-06
Completed
- Placebo-controlled randomized, double-blind study of zaltoprofen for patients with diffuse type tenosynovial giantcell tumor (Pigmented Villonodular Synovitis) and unresectable localized tenosynovial giant cell tumor (tendon sheath giant cell tumor) (Phase II study)
- Diffuse type tenosynovial giant cell tumor (Pigmented Villonodular Synovitis) and localized tenosynovial giant cell tumor (tendon sheath giant cell tumor)
- Kanazawa University Hospital
- 2017-04-06
Completed
- Placebo-controlled randomized, double-blind study of zaltoprofen for patients with diffuse type tenosynovial giantcell tumor (Pigmented Villonodular Synovitis) and unresectable localized tenosynovial giant cell tumor (tendon sheath giant cell tumor) (Phase II study)
- Diffuse type tenosynovial giant cell tumor (Pigmented Villonodular Synovitis) and localized tenosynovial giant cell tumor (tendon sheath giant cell tumor)
- Kanazawa University Hospital
- 2017-04-06